CFS 2018 Volume 3 - Benefits of attending this year’s CFS!

Archive

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

35th Annual Miami Breast Cancer Conference®

22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma®

2nd Annual International Congress on Oncology Pathology™

19th Annual International Lung Cancer Congress®

New York GU™: 11th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies

2nd Annual School of Nursing Oncology™

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow

2nd Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

May 2017

April 2017

March 2017

February 2017

January 2017

December 2016

November 2016

October 2016

September 2016

August 2016

July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

December 2014

November 2014

September 2014

August 2014

CFS 2018 Volume 3 - Benefits of attending this year’s CFS!

Network with the top minds in oncology
Incorporate the latest clinical data into your practice
Challenge the experts with your most difficult cases
100+ Experts. 25 Tumor Types. 3 Days. 1 Meeting.

SUN	MON	TUES	WED	THURS	FRI	SAT
						1 Advances In™: The Evolving Role of Antibody-Drug Conjugates for Treatment of TNBC Expires on Oct 01, 2022 CME 1.0 “Off-the-Shelf” Allogeneic CAR T Cells Expires on Oct 01, 2022 CME 0.5
2	3	4	5	6	7 Medical Crossfire®: How the Experts Approach Testing and Treatment When Utilizing PARP Inhibitors for mCRPC Expires on Oct 07, 2022 CME 2.0 Narcolepsy In the Advanced Practice Setting—Utilizing Evidence-Based Care to Improve Patient Outcomes Expires on Oct 07, 2022 CME 1.0 Expert Illustrations & Commentaries™: Iron Deficiency in Patients With Chronic Kidney Disease – An Inside Look at Pathogenesis and Evidence-Based Management Expires on Oct 07, 2022 CME 1.25	8
9	10	11	12	13	14 Medical Crossfire®: Individualizing Treatment in CRPC Based on Patient and Disease-Specific Factors Expires on Oct 14, 2022 CME 2.0 Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors Expires on Oct 14, 2022 CME 1.5	15 Oncology Briefings™: Update for Nurses on Novel Treatment and Management Approaches in Melanoma Expires on Oct 15, 2022 CME Advances In™ Breast Cancer: New Frontiers in the Management of ER+ Disease Expires on Oct 15, 2022 CME 1.0 Cancer Summaries and Commentaries®: Updates From Chicago on the Treatment of Lung Cancer Expires on Oct 15, 2022 CME 1.25 Expert Illustrations & Commentaries™: Reshaping the Clinical Landscape of HR-MDS Through Novel Mechanisms of Action Expires on Oct 15, 2022 CME 1.25 6th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) October 15, 2022 New York, NY
16	17	18	19	20 2021 Annual Psychiatric Times™ World CME Conference™ Expires on Oct 20, 2022 CME 18.5	21	22 Personalizing Care for Patients With Low- to High-Risk MDS: Applying the Science to Real-World Case Scenarios Expires on Oct 22, 2022 CME 1.5
23	24	25 “D” is for Diagnosis® - Cracking the Case in Rare Disorders with Respiratory Symptoms: Practical Approaches to Identification and Clinical Management Expires on Oct 25, 2022 CME 1.5	26 Oncology Consultations®: Challenging the Experts on How They Treat and Individualize Care in NSCLC with ALK Inhibitors Expires on Oct 26, 2022 CME 2.0 Advances in™ Bipolar Depression: Expert Strategies to Optimize Patient Outcomes in Depressive Episodes Expires on Oct 26, 2022 CME 1.0 Clinical Consultations™: Finding Opportunities to Improve the Management of Patients with Connective Tissue Disease-associated Pulmonary Arterial Hypertension (CTD-PAH) Expires on Oct 26, 2022 CME 1.0	27 3rd Annual International Congress on the Future of Neurology® Expires on Oct 27, 2022 CME 12.5 A Family Physician's Guide to Chronic Kidney Disease: Evolving Strategies and Emerging Data Expires on Oct 27, 2022 CME 1.5	28 Clinical ShowCase™: Applying the Evidence to Case Scenarios in Relapsed/Refractory Multiple Myeloma Expires on Oct 28, 2022 CME 0.75	29 Oncology Briefings™: Navigating Novel Emerging Chemotherapeutic Regimens for Patients with ALL Expires on Oct 29, 2022 CME 1.0 2021 SOHO ISS: Medical Crossfire®: How Can We Leverage Emerging Data to Optimize Outcomes Across Lines of Care in AML? Expires on Oct 29, 2022 CME 1.5 Community Practice Connections™: Medical Crossfire®: How Are We Integrating New Treatment Strategies Into the Care of Our B-Cell Lymphoma Patients? Expires on Oct 29, 2022 CME 1.5 Community Practice Connections™: 5th Annual School of Nursing Oncology™ Expires on Oct 29, 2022 CME 1.50 Community Practice Connections™: 22nd Annual International Lung Cancer Congress® Expires on Oct 29, 2022 CME 2.0 Protecting Our Patients From ASCVD: Optimizing the Use of Non-Statin Therapies Expires on Oct 29, 2022 CME 1.0 Expert Illustrations & Commentaries: Exploring the Rationale and Application of XPO1 Inhibitors in Hematologic Malignancies Expires on Oct 29, 2022 CME 1.0 Opportunities to Strengthen Osteoporosis Treatment and Prevention Practices in Primary Care Expires on Oct 29, 2022 CME 1.50 Triple-Negative Breast Cancer: Perspectives on the Disparities in Care and Managed Care Considerations for the Advancing Treatment Paradigm Expires on Oct 29, 2022 CME 1.5
30	31

Network with the top minds in oncology

Incorporate the latest clinical data into your practice

Challenge the experts with your most difficult cases

100+ Experts. 25 Tumor Types. 3 Days. 1 Meeting.